Request Deal Involvement

Grünenthal to acquire Valinor Pharma for $250m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

RBC Capital Markets

financial advisors

RBC Capital Markets

Wells Fargo Securities

financial advisors

Wells Fargo Securities

McDermott Will & Emery

legal advisors

McDermott Will & Emery

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

Grant Thornton

financial advisors

Grant Thornton

or

Principals

VALINOR PHARMA

target

VALINOR PHARMA

GRUNENTHAL

bidder

GRUNENTHAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Grünenthal to acquire Valinor Pharma for $250m.